Purchase Order 75N90024P00630

Award Date 9/11/24
Potential Completion Date 10/10/24
Potential Value $62K
Federal Agency
NIH Clinical Center
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
West Sacramento, CA 95605, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institutes of Health (NIH) awarded Gemini Bioproducts, LLC a $63,530 firm fixed-price purchase order for the supply of GemCell Plus Xeno Free cell culture media. The contract has an ultimate completion date of March 13, 2025 and does not utilize a set-aside designation. Gemini Bioproducts is a leading manufacturer and supplier of cell culture products, with a history of previous federal contract awards from agencies like the U.S. Department of Agriculture and the Federal Emergency...
This $3,501.23 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Gemini Bioproducts LLC. Gemini Bioproducts is a leading manufacturer and supplier of cell culture media, sera, and other reagents to the scientific community, including academic research and the biotechnology, cell and gene therapy, and biopharma industries. The contract is to provide fetal bovine serum, viral...
This is a federal contract award to Gemini Bioproducts LLC, a leading manufacturer and supplier of cell culture media, sera, and other reagents, by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH). The contract has a total ceiling value of $26,000.00 and is for the supply of biomaterial products. The contract type is a firm fixed-price purchase order, with an ultimate completion date of October 21, 2015. This award is not associated...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Gemini Bioproducts LLC. The $57,375.00 firm-fixed-price purchase order was for the delivery of 500 mL of benchmark fetal bovine serum, a critical cell culture component used in biomedical research. This order is part of NIAID's ongoing procurement of specialized cell culture media and reagents to support its diverse scientific initiatives....
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Gemini Bioproducts LLC. The $14,745.00 award is for in vitro diagnostic substances, reagents, test kits, and sets. Gemini Bioproducts is a leading manufacturer and supplier of cell culture media, sera, and other reagents to the scientific community across academic research, biotechnology, cell and gene therapy, and...
This federal contract award was made by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Gemini Bioproducts LLC, a for-profit manufacturer of cell culture media, sera, and other reagents. The $11,739 firm-fixed price contract is a Blanket Purchase Agreement (BPA) call that provides Gemini's products in support of biomedical research and emergency response efforts. Gemini has received prior sole-source awards from the National Institutes of...
This is a $79,875 firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to small business Gemini Bioproducts LLC. The contract is to provide cell culture media, sera, and other reagents in support of biomedical research and emergency response efforts. Gemini Bioproducts is a manufacturer and supplier of these products to the scientific community. This contract is set aside for small businesses. Gemini Bioproducts also...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Gemini Bioproducts LLC. The $6,165.00 firm fixed-price purchase order is for the delivery of 500 ml bottles of fetal bovine serum, a critical cell culture reagent used in biomedical research and pharmaceutical development. The contract has no set-aside designation. Gemini Bioproducts is a leading manufacturer and supplier of cell culture...
This firm fixed-price purchase order was awarded to Gemini Bioproducts LLC, a for-profit manufacturer of goods, by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases. The $102,116.06 contract is for the delivery of fetal bovine serum, and is designated as a Total Small Business set-aside. Gemini Bioproducts is a leading supplier of cell culture media, sera, and other reagents to the scientific community, including...
This is a Blanket Purchase Agreement (BPA) call awarded to Gemini Bioproducts LLC, a leading manufacturer and supplier of cell culture media, sera, and other reagents, by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH). The $27,000 contract is for a firm fixed price order for the delivery of unspecified products, likely related to the company's past awards to provide fetal bovine serum, viral transport media, and saline tubes in support of biomedical...

This $61,728 firm fixed price purchase order was awarded on September 11, 2024 to Gemini Bioproducts LLC, a for-profit manufacturer of cell culture media, sera, and other reagents. The contract supports the National Institutes of Health (NIH) Clinical Center with the supply of GemCell Plus Xeno-Free Lot H423031 products. Gemini Bioproducts has received prior sole source awards from NIH and the U.S. Department of Agriculture to provide specialized cell culture and viral transport media products. This award is not set aside and is part of a larger $200 million indefinite delivery, indefinite quantity (IDIQ) contract that Gemini holds with the Federal Emergency Management Agency (FEMA) to rapidly procure COVID-19 response supplies.

Generated 9/10/24, 11:01 AM